CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Assets
Cash and cash equivalents	$ 5,155	$ 15,992
Accounts receivable, net	14,022	13,728
Revenue earned but not billed	4,539	1,320
Inventories	18,246	18,205
Prepaid expenses and other current assets	2,860	1,116
Total current assets	44,822	50,361
Property and equipment, net	9,593	10,470
Goodwill	1,484	1,484
Other intangible assets, net	4,462	6,004
Other long-term assets	2,808	3,260
Total Assets	63,169	71,579
Liabilities and Shareholders’ Equity
Accounts payable	18,350	13,405
Accrued expenses and other	9,440	10,552
Deferred revenue, current	260	480
Current maturities of long-term debt	3	17
Total current liabilities	28,053	24,454
Revolving credit facility	10,000	10,000
Long-term debt, less current maturities	0	3
Deferred revenue, long-term	413	489
Other long-term liabilities	2,161	3,384
Total liabilities	40,627	38,330
Commitments and contingencies (Note 14)
Shareholders’ equity:
Preferred stock, $0.01 par value: Shares authorized: 30,000,000 shares at March 31, 2024 and 2023; no shares issued and outstanding at March 31, 2024 and 2023	0	0
Common stock, no par value: Shares authorized: 200,000,000 at March 31, 2024 and 2023; shares issued: 42,038,967 and 41,767,092 at March 31, 2024 and 2023; shares outstanding: 32,567,746 and 32,295,408 at March 31, 2024 and 2023	0	0
Additional paid-in capital	161,869	160,907
Treasury stock: 9,471,221 and 9,471,684 common shares at March 31, 2024 and 2023	(36,235)	(36,237)
Retained deficit	(103,092)	(91,421)
Total shareholders’ equity	22,542	33,249
Total liabilities and shareholders’ equity	$ 63,169	$ 71,579